Lamotrigine Tablet
Product Images NDC 13668-045

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 13668-045). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (5a15187f B147 4147 A4ef 0e3e5de73cb6 01)

Chemical structure of lamotrigine, a prescription drug active ingredient. The structure shows a chlorinated aromatic ring and a triazine ring with amino groups attached.*

FDA Label Image

Graph (5a15187f B147 4147 A4ef 0e3e5de73cb6 02)

A line graph showing failure probability (%) on the vertical axis versus weeks on the horizontal axis. Two curves are plotted, labeled Placebo and Lamotrigine, with a notation for censored data points. The graph depicts comparative failure probability trends over approximately 100 weeks for Lamotrigine and Placebo groups.*

FDA Label Image

Graph (5a15187f B147 4147 A4ef 0e3e5de73cb6 03)

A Kaplan-Meier failure probability curve comparing Lamotrigine and placebo over a period of approximately 80 weeks. The vertical axis shows failure probability in percentage, and the horizontal axis shows time in weeks. The curves indicate failure probability trends for both Lamotrigine and placebo treatment groups, with censored data points marked along the lines.*

FDA Label Image

Image 2 (Logo1)

FDA Label Image

Image (708290c4 B959 47cc 95a1 38a6270297e5 1119 2)

An illustration showing the dimensional drawings of Lamotrigine tablets in four strengths: 25 mg, 100 mg, 150 mg, and 200 mg. Each strength is depicted with an upper face showing specific embossed numbers and a lower face featuring a scored line or plain surface for identification.*

FDA Label Image

25mg-indrad (Lamotrigine Tablets 25 mg 30 Count Indrad)

Label for Lamotrigine Tablets, USP 25 mg oral tablets by Torrent Pharmaceuticals Limited. The label indicates a package size of 30 tablets, with storage instructions, dosage caution, a barcode, and manufacturer information. The design features a white background, pink accent behind the strength text, and the product strength prominently displayed as 25 mg.*

FDA Label Image

25mg-dahej (Lamotrigine Tablets 25mg 30 Count Dahej)

Lamotrigine Tablets, USP 25 mg oral tablets label from Torrent Pharmaceuticals Limited. The label indicates a 30-tablet count, storage instructions, dosage caution, NDC 13668-045-30, and dispensing guidance with accompanying Medication Guide.*

FDA Label Image

25mg-vkt (25mg Vkt)

Lamotrigine Tablets, USP 25 mg label for a package of 100 tablets by Torrent Pharmaceuticals Limited. The label includes storage instructions, a caution to verify the product dispensed, a barcode, and manufacturer information for VKT Pharma Private Limited in India, plus the distributor Torrent Pharma INC in New Jersey.*

FDA Label Image

100mg-indrad (Lamotrigine Tablets 100mg 30 Count Indrad)

Label for Lamotrigine Tablets USP 100 mg, oral tablets packaged in a container of 30 tablets. The label indicates storage instructions, dosage information referencing accompanying prescribing information, and includes the NDC number 13668-047-30. Manufactured by Torrent Pharmaceuticals Limited and labeled as Rx only.*

FDA Label Image

100mg-dahej (Lamotrigine Tablets 100mg 30count Dahej)

Label for Lamotrigine Tablets, USP 100 mg, oral tablets. The label indicates a package of 30 tablets from Torrent Pharmaceuticals Limited. It includes storage instructions, dosage notes referring to accompanying prescribing information, and a caution to verify the product dispensed. The label displays the NDC number 13668-047-30 and emphasizes the product is Rx only.*

FDA Label Image

100mg-vkt (100mg Vkt)

Label for Lamotrigine Tablets, USP 100 mg in tablet form, packaged as 100 tablets. The label includes storage instructions, cautions to dispense the medication guide, the NDC 13668-047-01, and notes that it is for prescription use only. Manufactured by Torrent Pharmaceuticals Limited, the label features the Torrent Pharma logo and barcode.*

FDA Label Image

150mg-indrad (Lamotrigine Tablets 150mg 30count Indrad)

Lamotrigine Tablets, USP 150 mg oral tablets packaging label by Torrent Pharmaceuticals Limited. The label states 30 tablets per package, cautions to verify product dispersion, and includes storage instructions and dosage guidance referencing accompanying prescribing information. The NDC number 13668-048-30 is visible along with a barcode.*

FDA Label Image

150mg-dahej (Lamotrigine Tablets 150mg 30count Dahej)

Label for Lamotrigine Tablets, USP 150 mg, oral tablet dosage form. The label includes storage instructions, dosage cautions, and a QR code. Manufactured by Torrent Pharmaceuticals Limited and labeled for Torrent Pharma Inc. The label states it contains 30 tablets and is marked Rx only.*

FDA Label Image

150mg-vkt (150mg Vkt)

Label for Lamotrigine Tablets, USP 150 mg oral tablets by Torrent Pharmaceuticals Limited. The package contains 60 tablets. Includes dosage instructions to see prescriber information and storage conditions between 20° to 25°C. The label features the NDC number 13668-048-60 and cautions to verify the product dispensed.*

FDA Label Image

200mg-indrad (Lamotrigine Tablets 200mg 30count Indrad)

Lamotrigine Tablets, USP 200 mg oral tablet packaging label from Torrent Pharmaceuticals Limited. The label indicates a 30-tablet bottle with NDC 13668-049-30. It includes storage instructions, caution to verify the product dispensed, and user directions to dispense medication guides with the product. Manufacturer information for Torrent Pharmaceuticals LTD, India, and Torrent Pharma Inc., New Jersey, is present.*

FDA Label Image

200mg-dahej (Lamotrigine Tablets 200mg 30count Dahej)

Lamotrigine Tablets, USP 200 mg oral tablets label from Torrent Pharmaceuticals Limited. The carton label states the product contains 200 mg lamotrigine per tablet, includes storage instructions, and cautions to verify the product dispensed. It is an Rx only medication and the package contains 30 tablets with NDC 13668-049-30.*

FDA Label Image

200mg-vkt (200mg Vkt)

Lamotrigine Tablets, USP 200 mg oral tablets in a 60-tablet package. The label includes storage instructions, caution to verify the product dispensed, and directs users to the Medication Guide. Manufactured by VKT Pharma Private Limited and labeled by Torrent Pharmaceuticals Limited. NDC 13668-049-60 is visible alongside a barcode.*

FDA Label Image

Orange-kit (Orange Kit)

Lamotrigine Tablets, USP Starter Kit packaging label showing 25 mg and 100 mg tablets. The label includes dosage instructions for titration, warnings for patients not taking specific anticonvulsants, and prescribing cautions. The labeler is Torrent Pharmaceuticals Limited. The packaging indicates prescription use only and includes an NDC number and barcode.*

FDA Label Image

Green-kit (Green Kit)

Lamotrigine Tablets, USP Starter Kit packaging label by Torrent Pharmaceuticals Limited. The label shows tablets in strengths of 25 mg and 100 mg for oral use. The design includes dosage instructions, cautionary notes, and reminders for patients taking certain other medications. The primary colors are white and green with blue text, highlighting the product name and starter kit information.*

FDA Label Image

Blue-kit (Blue Kit)

Packaging label for Lamotrigine Tablets, USP Starter Kit 25 mg oral tablets by Torrent Pharmaceuticals Limited. The label specifies it is for patients taking valproate and contains 35 tablets arranged in 5 unit doses of 7 tablets each. The label includes dosing instructions for weeks 1 through 5 and a barcode. The NDC is 13668-045-29.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.